What Goes in Must Come out: Testing for Biases in Molecular Analysis of Arbuscular Mycorrhizal Fungal Communities

Por Cotton, T. E. Anne, Dumbrell, Alex J., Helgason, Thorunn
Publicado em 2014

Increasing flooding frequency alters soil microbial communities and functions under laboratory conditions

Por Randle‐Boggis, Richard J., Ashton, Peter D., Helgason, Thorunn
Publicado no Microbiologyopen (2017)

Evaluating techniques for metagenome annotation using simulated sequence data

Por Randle-Boggis, Richard J., Helgason, Thorunn, Sapp, Melanie, Ashton, Peter D.
Publicado no FEMS Microbiol Ecol (2016)

Isolation and characterization of metaldehyde‐degrading bacteria from domestic soils

Por Thomas, John C., Helgason, Thorunn, Sinclair, Chris J., Moir, James W. B.
Publicado no Microb Biotechnol (2017)

Local Adaptation to Soil Hypoxia Determines the Structure of an Arbuscular Mycorrhizal Fungal Community in Roots from Natural CO(2) Springs

Por Maček, Irena, Dumbrell, Alex J., Nelson, Michaela, Fitter, Alastair H., Vodnik, Dominik, Helgason, Thorunn
Publicado em 2011

Fungi in the future: interannual variation and effects of atmospheric change on arbuscular mycorrhizal fungal communities

Por Cotton, T E Anne, Fitter, Alastair H, Miller, R Michael, Dumbrell, Alex J, Helgason, Thorunn
Publicado no New Phytol (2015)

Biogeography of Paenibacillus larvae, the causative agent of American foulbrood, using a new multilocus sequence typing scheme

Por Morrissey, Barbara J, Helgason, Thorunn, Poppinga, Lena, Fünfhaus, Anne, Genersch, Elke, Budge, Giles E
Publicado no Environ Microbiol (2015)

Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies

Por Jain, Rajul K, Hong, David S, Naing, Aung, Wheler, Jennifer, Helgason, Thorunn, Shi, Nai-Yi, Gad, Yash, Kurzrock, Razelle
Publicado no Cell Cycle (2015)

Soil fungal networks maintain local dominance of ectomycorrhizal trees

Por Liang, Minxia, Johnson, David, Burslem, David F. R. P., Yu, Shixiao, Fang, Miao, Taylor, Joe D., Taylor, Andy F. S., Helgason, Thorunn, Liu, Xubing
Publicado no Nat Commun (2020)

A Phase I Trial of Liposomal Doxorubicin, Bevacizumab and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies

Por Moroney, John W., Schlumbrecht, Matthew P., Helgason, Thorunn, Coleman, Robert L., Moulder, Stacy, Naing, Aung, Bodurka, Diane C., Janku, Filip, Hong, David S., Kurzrock, Razelle
Publicado em 2011

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

Por Wheler, Jennifer, Hong, David, Swisher, Stephen G., Falchook, Gerald, Tsimberidou, Apostolia M., Helgason, Thorunn, Naing, Aung, Stephen, Bettzy, Janku, Filip, Stephens, Philip J., Yelensky, Roman, Kurzrock, Razelle
Publicado em 2013

Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase 1 Trial

Por Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Chawla, Sant, Falchook, Gerald, Hong, David, Akcakanat, Argun, Chen, Huiqin, Naing, Aung, Fu, Siqing, Wheler, Jennifer, Moulder, Stacy, Helgason, Thorunn, Li, Shaoyi, Elias, Ileana, Desai, Neil, Kurzrock, Razelle
Publicado em 2013

Mechanistic strategies of microbial communities regulating lignocellulose deconstruction in a UK salt marsh

Por Leadbeater, Daniel R., Oates, Nicola C., Bennett, Joseph P., Li, Yi, Dowle, Adam A., Taylor, Joe D., Alponti, Juliana Sanchez, Setchfield, Alexander T., Alessi, Anna M., Helgason, Thorunn, McQueen-Mason, Simon J., Bruce, Neil C.
Publicado no Microbiome (2021)

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

Por Basho, Reva K., Yam, Clinton, Gilcrease, Michael, Murthy, Rashmi K., Helgason, Thorunn, Karp, Daniel D., Meric‐Bernstam, Funda, Hess, Kenneth R., Valero, Vicente, Albarracin, Constance, Litton, Jennifer K., Chavez‐MacGregor, Mariana, Hong, David, Kurzrock, Razelle, Hortobagyi, Gabriel N., Janku, Filip, Moulder, Stacy L.
Publicado no Oncologist (2018)

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant

Por Litton, Jennifer K., Scoggins, Marion E., Hess, Kenneth R., Adrada, Beatriz E., Murthy, Rashmi K., Damodaran, Senthil, DeSnyder, Sarah M., Brewster, Abenaa M., Barcenas, Carlos H., Valero, Vicente, Whitman, Gary J., Schwartz-Gomez, Jill, Mittendorf, Elizabeth A., Thompson, Alastair M., Helgason, Thorunn, Ibrahim, Nuhad, Piwnica-Worms, Helen, Moulder, Stacy L., Arun, Banu K.
Publicado no J Clin Oncol (2020)

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

Por Roberts, Nicholas J., Zhang, Linping, Janku, Filip, Collins, Amanda, Bai, Ren-Yuan, Staedtke, Verena, Rusk, Anthony W., Tung, David, Miller, Maria, Roix, Jeffrey, Khanna, Kristen V., Murthy, Ravi, Benjamin, Robert S., Helgason, Thorunn, Szvalb, Ariel D., Bird, Justin E., Roy-Chowdhuri, Sinchita, Zhang, Halle H., Qiao, Yuan, Karim, Baktiar, McDaniel, Jennifer, Elpiner, Amanda, Sahora, Alexandra, Lachowicz, Joshua, Phillips, Brenda, Turner, Avenelle, Klein, Mary K., Post, Gerald, Diaz, Luis A., Riggins, Gregory J., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Bettegowda, Chetan, Huso, David L., Varterasian, Mary, Saha, Saurabh, Zhou, Shibin
Publicado no Sci Transl Med (2014)